Publication Name	World Journal of Hepatology
Manuscript ID	58668
Country	Australia

Received	2020-08-01 06:59
Peer-Review Started	2020-08-01 07:00
To Make the First Decision
Return for Revision	2020-09-24 16:50
Revised	2020-10-08 05:17
Second Decision	2020-10-23 10:58
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2020-10-26 17:03
Articles in Press	2020-10-26 17:03
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2020-12-04 08:15
Publish the Manuscript Online	2020-12-18 05:58

ISSN	1948-5182 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Minireviews
Article Title	Metabolic associated fatty liver disease: Addressing a new era in liver transplantation
Manuscript Source	Invited Manuscript
All Author List	Madeleine G Gill and Avik Majumdar
ORCID	Author(s) ORCID Number Madeleine G Gill http://orcid.org/0000-0002-4201-0173 Avik Majumdar http://orcid.org/0000-0003-2975-4327
Funding Agency and Grant Number
Corresponding Author	Avik Majumdar, FRACP, MBBS, PhD, Senior Lecturer, Staff Physician, Central Clinical School, The University of Sydney, Camperdown NSW 2006, Sydney 2050, New South Wales, Australia. avik.majumdar@health.nsw.gov.au
Key Words	Fatty liver; Metabolic associated fatty liver disease; Non-alcoholic fatty liver disease; Liver transplantation; Cirrhosis; Metabolic syndrome
Core Tip	Metabolic Associated Fatty Liver Disease (MAFLD), previously termed non-alcoholic fatty liver disease, is the leading global cause of liver disease and is becoming the most common indication for liver transplantation. Several challenges exist in the pre-, peri-and post-liver transplant setting for patients with MAFLD, which mostly relate to comorbid medical conditions, obesity and cardiovascular risk. Donor liver steatosis is also an increasing concern. In this review, we summarise the current literature and provide an approach to address the current challenges of MAFLD and liver transplantation.
Publish Date	2020-12-18 05:58
Citation	Gill MG, Majumdar A. Metabolic associated fatty liver disease: Addressing a new era in liver transplantation. World J Hepatol 2020; 12(12): 1168-1181
URL	https://www.wjgnet.com/1948-5182/full/v12/i12/1168.htm
DOI	https://dx.doi.org/10.4254/wjh.v12.i12.1168

Full Article (PDF)	WJH-12-1168.pdf
Full Article (Word)	WJH-12-1168.docx
Manuscript File	58668_Auto_Edited.docx
Answering Reviewers	58668-Answering reviewers.pdf
Audio Core Tip	58668-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	58668-Conflict-of-interest statement.pdf
Copyright License Agreement	58668-Copyright license agreement.pdf
Peer-review Report	58668-Peer-review(s).pdf
Scientific Misconduct Check	58668-Scientific misconduct check.pdf
Scientific Editor Work List	58668-Scientific editor work list.pdf
CrossCheck Report	58668-CrossCheck report.pdf